A brain implant for restoring sight will enter clinical trials
Second Sight, the company that created the first artificial retina for people with a certain form of blindness, is now testing a brain implant called Orion, according to MIT Technology Review. The USFDA has conditionally approved a clinical trial of the technology, and the company plans to start enrolling patients for the trial implants in October.
How it works: Electrodes send electrical pulses to the brain's visual cortex, which registers the information as patterns of light. (Typically the visual cortex receives input from the retina).